首页> 美国卫生研究院文献>Eurosurveillance >Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B northern Spain 2017/18
【2h】

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B northern Spain 2017/18

机译:三价流感疫苗在世袭错配的乙型流感主导的季节中的中期有效性西班牙北部2017/18

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.
机译:在纳瓦拉,2017/18年度三价流感疫苗有效性(VE)的中期估计为39%(95%置信区间:20-54)。与当前和之前五个季节未接种疫苗的个体相比,当前和任何先前剂量的针对B型流感的VE分别为41%,仅当前疫苗接种的为67%,任何先前剂量的为22%,43%,51%和54% ,分别针对A型流感(H3N2)。这表明尽管血统不匹配的乙型流感占主导地位,但中度VE。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号